Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3
Clinical trial NCT03488134 · COMPLETED
Trial details
- NCT number
- NCT03488134
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-03
- Primary completion
- 2023-07-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.